放射腫瘤學市場規模、佔有率和成長分析（按系統和軟體、技術、應用、治療方法和地區分類）—2026-2033年產業預測

預計到 2024 年，全球放射治療市場規模將達到 75.9 億美元，到 2025 年將達到 79.5 億美元，到 2033 年將達到 114.8 億美元，預測期（2026-2033 年）的複合年成長率為 4.7%。

受癌症發病率上升和對有效治療方法需求不斷成長的推動，全球放射治療市場正經歷顯著成長。隨著人口老化，罹患各種癌症的風險增加，人們對放射治療益處的認知也不斷提高，促使更多患者選擇這種治療方法。包括精準靶向照射和尖端成像技術在內的高科技放射治療設備的進步，提高了治療的有效性和安全性，吸引了患者和醫療服務提供者的注意。然而，挑戰仍然存在，例如缺乏掌握先進放射技術和複雜腫瘤可視化技術的合格人員，這可能會阻礙治療計劃的製定。同時，新興市場醫療基礎設施的改善和癌症治療覆蓋範圍的擴大，為市場帶來了巨大的成長機會。

全球放射治療市場促進因素

全球放射治療市場的成長主要受全球癌症發生率上升的推動。人口老化、生活方式的改變以及環境毒素暴露的增加是導致這一成長的主要因素。隨著癌症診斷數量的增加，對放射治療等有效治療方法的需求日益成長，這對於控制各種類型的癌症至關重要。此外，人們對早期診斷和及時治療重要性的認知不斷提高，預計將進一步增加對放射治療服務的需求，從而滿足這些緊迫的醫療需求，並最終推動市場擴張。

限制全球放射治療市場的因素

全球放射腫瘤市場面臨嚴峻挑戰，主要原因是高昂的成本限制了患者獲得必要的放射治療，尤其是中低收入國家。設備和治療費用高昂，阻礙了醫療機構投資先進技術。因此，經濟困難的患者往往難以獲得這項關鍵治療。這種情況造成了放射治療機會的巨大差異，尤其是在資源匱乏的地區。這反過來又阻礙了整個放射腫瘤市場的成長，並影響了患者在最需要的時候獲得關鍵癌症治療的能力。

全球放射治療市場趨勢

全球放射治療市場正經歷著向個人化醫療的顯著轉變，這正在改變放射線治療的研發和實施方式。基因和分子分析技術的進步使醫療服務提供者能夠根據每位患者獨特的生物學特徵量身定做放射治療方案。這種個人化方法不僅提高了治療效果，還最大限度地減少了副作用，最終實現了更精準的腫瘤標靶治療和更佳的患者預後。隨著個人化醫療研究的不斷深入，治療方法和策略也不斷改進，放射治療的未來正處於變革的邊緣。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球放射腫瘤市場規模（按系統和軟體分類）及複合年成長率（2026-2033 年）

• 系統
• 軟體和服務

全球放射腫瘤市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 體外放射治療技術
  • 直線加速器
  • 傳統直線加速器
  • 用於立體定位治療的先進電子束/鈷-60直線加速器
  • 磁共振直線加速器
  • 粒子束療法
  • 迴旋加速器
  • 同步輻射
  • 同步迴旋加速器
  • 常規鈷-60外照射放射治療
• 體內放射治療/近距離放射治療
  • 種子
  • 後荷機
  • IORT系統
  • 塗抹器

全球放射腫瘤市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 體外放射治療的適應症
  • 攝護腺癌
  • 乳癌
  • 肺癌
  • 頭頸癌
  • 大腸直腸癌
  • 其他體外放射治療應用
• 內放射治療/近距離放射治療的適應症
  • 攝護腺癌
  • 婦科癌症
  • 乳癌
  • 子宮頸癌
  • 陰莖癌
  • 內放射治療/近距離放射治療的其他適應症

全球放射腫瘤市場規模（按治療方法類型和複合年成長率分類）（2026-2033 年）

• 體外放射治療
  • 影像導航放射治療
  • 強度調控放射治療
  • 3D適形放射治療
  • 立體定位放射治療
  • 粒子束療法
  • 其他體外放射治療技術
• 內照射放射線治療/近距離放射治療
  • 低劑量率（LDR）近距離放射
  • 高劑量率近距離近距離放射
  • PDR近距離放射治療

全球放射腫瘤市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Accuray Incorporated（USA）
• Elekta AB（Sweden）
• IBA（Ion Beam Applications SA）（Belgium）
• Isoray Medical Inc.（USA）
• Eckert & Ziegler Group（Germany）
• Nordion Inc.（Canada）
• Mevion Medical Systems（USA）
• Hitachi, Ltd.（Japan）
• ViewRay Technologies, Inc.（USA）
• Panacea Medical Technologies Pvt. Ltd.（India）
• Canon Medical Systems Corporation（Japan）
• RaySearch Laboratories（Sweden）
• Mitsubishi Electric Corporation（Japan）
• NTP Radioisotopes SOC Ltd.（South Africa）
• RefleXion（USA）
• Toshiba Energy Systems & Solutions Corporation（Japan）
• P-Cure Ltd.（Israel）
• Provision Healthcare（USA）
• Brainlab AG（Germany）

結論與建議

Global Radiotherapy Market size was valued at USD 7.59 Billion in 2024 and is poised to grow from USD 7.95 Billion in 2025 to USD 11.48 Billion by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).

The global radiotherapy market is witnessing substantial growth driven by the rising incidence of cancer and an increasing demand for effective treatment options. As the aging population becomes more susceptible to various cancers, there is heightened awareness of the benefits of radiotherapy, encouraging more patients to seek this form of treatment. Advances in high-tech radiotherapy devices, including precision targeting and cutting-edge imaging technologies, have enhanced treatment efficacy and safety, drawing interest from both patients and healthcare providers. Nonetheless, challenges persist due to a shortage of qualified professionals trained in advanced radiation techniques and complexities related to tumor visualization that can hinder treatment planning. Conversely, emerging markets present significant opportunities for growth as healthcare infrastructure improves and access to cancer treatments expands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radiotherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radiotherapy Market Segments Analysis

Global Radiotherapy Market is segmented by System And Software, Technology, Application, Procedure and region. Based on System And Software, the market is segmented into Systems and Software & Services. Based on Technology, the market is segmented into External Beam Radiotherapy Technologies and Internal Beam Radiotherapy/Brachytherapy. Based on Application, the market is segmented into External Beam Radiotherapy Applications and Internal Beam Radiotherapy/Brachytherapy Applications. Based on Procedure, the market is segmented into External Beam Radiotherapy and Internal Beam Radiotherapy/Brachytherapy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Radiotherapy Market

The global radiotherapy market is significantly driven by the escalating incidence of cancer worldwide. Several key factors contribute to this rise, including an aging population, shifts in lifestyle choices, and heightened exposure to environmental toxins. As the number of cancer diagnoses grows, the demand for effective treatment options like radiation therapy becomes increasingly critical for managing various types of cancer. Additionally, growing awareness surrounding the importance of early diagnosis and timely treatment is expected to further elevate the necessity for radiotherapy services, ultimately propelling the market's expansion in response to these pressing healthcare needs.

Restraints in the Global Radiotherapy Market

The global radiotherapy market faces considerable challenges due to significant cost barriers that restrict access to essential radiation treatments, particularly in low- and middle-income countries. The high expenses associated with both equipment and procedures deter healthcare institutions from investing in advanced technology. Consequently, patients experiencing financial difficulties often struggle to afford these critical treatments. This situation creates a substantial gap in access to radiotherapy, especially in areas where healthcare resources are limited. As a result, the overall growth of the radiotherapy market is impeded, impacting patients' ability to receive vital cancer care when needed most.

Market Trends of the Global Radiotherapy Market

The Global Radiotherapy market is experiencing a significant trend towards personalized healthcare, marking a shift in how radiation therapies are developed and administered. As advancements in genetic and molecular profiling emerge, healthcare providers are increasingly able to customize radiation treatment regimens to align with each patient's unique biological characteristics. This tailored approach not only enhances the effectiveness of treatments but also minimizes side effects, ultimately leading to improved tumor targeting and better patient outcomes. The future of radiotherapy is poised for transformation, driven by ongoing research in personalized medicine, which will further refine treatment modalities and approaches.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Radiotherapy Market Size by System And Software & Service & CAGR (2026-2033)

• Market Overview
• Systems
• Software & Services

Global Radiotherapy Market Size by Technology & CAGR (2026-2033)

• Market Overview
• External Beam Radiotherapy Technologies
  • Linacs
  • Conventional Linacs
  • Stereotactic Advanced Electron/Cobalt-60 Linacs
  • Mri Linacs
  • Particle Therapy
  • Cyclotrons
  • Synchrotrons
  • Synchrocyclotrons
  • Conventional Cobalt-60 Teletherapy
• Internal Beam Radiotherapy/Brachytherapy
  • Seeds
  • Afterloaders
  • IORT Systems
  • Applicators

Global Radiotherapy Market Size by Application & CAGR (2026-2033)

• Market Overview
• External Beam Radiotherapy Applications
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head & Neck Cancer
  • Colorectal Cancer
  • Other External Beam Radiotherapy Applications
• Internal Beam Radiotherapy/Brachytherapy Applications
  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Cervical Cancer
  • Penile Cancer
  • Other Internal Beam Radiotherapy/Brachytherapy Applications

Global Radiotherapy Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• External Beam Radiotherapy
  • Image-Guided Radiotherapy
  • Intensity-Modulated Radiotherapy
  • 3d Conformal Radiotherapy
  • Stereotactic Radiotherapy
  • Particle Therapy
  • Other External Beam Radiotherapy Procedures
• Internal Beam Radiotherapy/Brachytherapy
  • LDR Brachytherapy
  • HDR Brachytherapy
  • PDR Brachytherapy

Global Radiotherapy Market Size & CAGR (2026-2033)

• North America (System And Software & Service, Technology, Application, Procedure)
  • US
  • Canada
• Europe (System And Software & Service, Technology, Application, Procedure)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (System And Software & Service, Technology, Application, Procedure)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (System And Software & Service, Technology, Application, Procedure)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (System And Software & Service, Technology, Application, Procedure)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Accuray Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA (Ion Beam Applications SA) (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Isoray Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eckert & Ziegler Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mevion Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViewRay Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panacea Medical Technologies Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RaySearch Laboratories (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Electric Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NTP Radioisotopes SOC Ltd. (South Africa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RefleXion (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toshiba Energy Systems & Solutions Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• P-Cure Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Provision Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations